Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-01-23 @ 2:29 PM
Study NCT ID:
NCT04501757
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-12-08
First Post:
2020-07-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Naxitamab and GM-CSF in People With Neuroblastoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | High-Risk Neuroblastoma | View |